SYNTA PHARMACEUTICALS CORP's ticker is SNTA and the CUSIP is 87162T206. A total of 68 filers reported holding SYNTA PHARMACEUTICALS CORP in Q1 2016. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $0 | – | 400 | 0.0% | 0.00% | – |
| Q4 2015 | $0 | -100.0% | 400 | 0.0% | 0.00% | – |
| Q3 2015 | $1,000 | 0.0% | 400 | 0.0% | 0.00% | – |
| Q2 2015 | $1,000 | 0.0% | 400 | 0.0% | 0.00% | – |
| Q1 2015 | $1,000 | 0.0% | 400 | 0.0% | 0.00% | – |
| Q4 2014 | $1,000 | -80.0% | 400 | -68.0% | 0.00% | – |
| Q2 2014 | $5,000 | -73.7% | 1,250 | -58.3% | 0.00% | – |
| Q3 2013 | $19,000 | – | 3,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON CORP | 30,197,945 | $80,025,000 | 92.06% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 457,458 | $1,212,000 | 0.22% |
| Verity Asset Management, Inc. | 82,383 | $218,000 | 0.21% |
| STONERIDGE INVESTMENT PARTNERS LLC | 332,238 | $880,000 | 0.12% |
| Cutler Capital Management, LLC | 62,500 | $165,000 | 0.07% |
| Capital Impact Advisors, LLC | 37,788 | $100,000 | 0.05% |
| SECOR Capital Advisors, LP | 35,087 | $93,000 | 0.04% |
| STRATEGIC INVESTMENT MANAGEMENT, LLC | 50,814 | $134,000 | 0.04% |
| BOLTON LP | 37,700 | $100,000 | 0.03% |
| BOLTON LP | 37,700 | $100,000 | 0.03% |